These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37408815)

  • 41. [ABO incompatible living donor kidney transplantation in a center in Córdoba, Argentina].
    Borgogno P; Fernández P; Douthat W; de Arteaga J; Damonte JC; Giacomi V; de la Fuente J; Chiurchiu C
    Medicina (B Aires); 2021; 81(6):986-995. PubMed ID: 34875598
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Outcome of desensitization in human leukocyte antigen and ABO incompatible living donor kidney transplantation: Single center experience of first 200 incompatible transplants.
    Pandey P; Setya D; Sinha VK; Devra AK; Bhatt AP; Pande A; Kumar P; Singh MK; Ranjan S
    J Clin Apher; 2021 Jun; 36(3):299-312. PubMed ID: 33316838
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outcome comparison of ABO-incompatible kidney transplantation with low-dose rituximab and ABO-compatible kidney transplantation: a single-center experience.
    Hatakeyama S; Fujita T; Murakami R; Suzuki Y; Sugiyama N; Yamamoto H; Okamoto A; Imai A; Tobisawa Y; Yoneyama T; Mori K; Yoneyama T; Hashimoto Y; Koie T; Narumi S; Ohyama C
    Transplant Proc; 2014; 46(2):445-8. PubMed ID: 24655984
    [TBL] [Abstract][Full Text] [Related]  

  • 44. ABO-incompatible kidney transplantation using antigen-specific immunoadsorption and rituximab: a 3-year follow-up.
    Genberg H; Kumlien G; Wennberg L; Berg U; Tydén G
    Transplantation; 2008 Jun; 85(12):1745-54. PubMed ID: 18580466
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Histological and Extended Clinical Outcomes After ABO-Incompatible Renal Transplantation Without Splenectomy or Rituximab.
    Chow KV; Flint SM; Shen A; Landgren A; Finlay M; Murugasu A; Masterson R; Hughes P; Cohney SJ
    Transplantation; 2017 Jun; 101(6):1433-1440. PubMed ID: 27495772
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Economic Impacts of ABO-Incompatible Live Donor Kidney Transplantation: A National Study of Medicare-Insured Recipients.
    Axelrod D; Segev DL; Xiao H; Schnitzler MA; Brennan DC; Dharnidharka VR; Orandi BJ; Naik AS; Randall H; Tuttle-Newhall JE; Lentine KL
    Am J Transplant; 2016 May; 16(5):1465-73. PubMed ID: 26603690
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Progression of histological lesions after ABO incompatible kidney transplantation.
    Guy P; Delas A; Esposito L; Cointault O; Colombat M; Congy-Jolivet N; Raynaud M; Kamar N; Del Bello A
    Front Immunol; 2022; 13():969998. PubMed ID: 36275771
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ABO-incompatible renal transplantation in developing world - crossing the immunological (and mental) barrier.
    Jha PK; Bansal SB; Sethi SK; Jain M; Sharma R; Nandwani A; Phanish MK; Duggal R; Tiwari AK; Ghosh P; Ahlawat R; Kher V
    Indian J Nephrol; 2016; 26(2):113-8. PubMed ID: 27051135
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Biliary stricture is the only concern in ABO-incompatible adult living donor liver transplantation in the rituximab era.
    Song GW; Lee SG; Hwang S; Kim KH; Ahn CS; Moon DB; Ha TY; Jung DH; Park GC; Kang SH; Jung BH; Yoon YI; Kim N
    J Hepatol; 2014 Sep; 61(3):575-82. PubMed ID: 24801413
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ABO-Incompatible Liver Transplantation - A Review of the Historical Background and Results.
    Dahlgren US; Bennet W
    Int Rev Immunol; 2019; 38(3):118-128. PubMed ID: 31012340
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inclusive ABO-Incompatible Listing for Pediatric Heart Transplantation Results in Comparable Post-Transplant Rejection-Free Survival in a Single-Center Series.
    Downs EA; Schäfer M; Everitt MD; Aubrey M; Mitchell M; Jaggers J; Campbell D; Stone ML
    Pediatr Cardiol; 2024 Aug; ():. PubMed ID: 39115706
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Successful ABO and HLA incompatible kidney transplantation in children in the UK.
    Hew EY; Kessaris N; Stojanovic J; Jones H; Christian M; Edwards A; Milford DV; Ognjanovic M; Shenoy M; Baker RJ; Marks SD
    Pediatr Nephrol; 2023 Feb; 38(2):529-535. PubMed ID: 35695967
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ABO Incompatible Living Donor Liver Transplantation in Children: A Single Centre Experience from India.
    Gautam V; Kumar V; Agarwal S; Gupta S
    J Clin Exp Hepatol; 2024; 14(3):101340. PubMed ID: 38283705
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of ABO incompatible kidney transplantation on living donor transplantation.
    Yu JH; Chung BH; Yang CW;
    PLoS One; 2017; 12(3):e0173878. PubMed ID: 28323892
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ABO-Incompatible Heart Transplant in Infants: A UNOS Database Review.
    Kozik D; Sparks J; Trivedi J; Slaughter MS; Austin E; Alsoufi B
    Ann Thorac Surg; 2021 Aug; 112(2):589-594. PubMed ID: 32888926
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of clinical outcomes between ABO-compatible and ABO-incompatible spousal donor kidney transplantation.
    Park WY; Kang SS; Park SB; Park UJ; Kim HT; Cho WH; Han S
    Kidney Res Clin Pract; 2016 Mar; 35(1):50-4. PubMed ID: 27069858
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hyporesponsiveness against donor's ABO antigens of renal grafts after ABO-incompatible kidney transplantation.
    Tasaki M; Tateno H; Sato T; Narimatsu H; Saito K; Nakagawa Y; Aoki T; Kamimura M; Ushiki T; Takahashi K; Tomita Y
    Clin Exp Nephrol; 2023 Jan; 27(1):89-95. PubMed ID: 36209259
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Borderline rejection in ABO-incompatible kidney transplantation.
    Sánchez-Escuredo A; Oppenheimer F; Solé M; Revuelta I; Cid J; Lozano M; Blasco M; Esforzado N; Ricart MJ; Cofán F; Torregrosa JV; Paredes D; Musquera M; Ercilla G; Campistol JM; Diekmann F
    Clin Transplant; 2016 Aug; 30(8):872-9. PubMed ID: 27146439
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Optimizing repeat liver transplant graft utility through strategic matching of donor and recipient characteristics.
    Hung K; Gralla J; Dodge JL; Bambha KM; Dirchwolf M; Rosen HR; Biggins SW
    Liver Transpl; 2015 Nov; 21(11):1365-73. PubMed ID: 25865434
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association between the early high level of serum tacrolimus and recurrence of hepatocellular carcinoma in ABO-incompatible liver transplantation.
    Han JW; Choi JY; Jung ES; Kim JH; Cho HS; Yoo JS; Sung PS; Jang JW; Yoon SK; Choi HJ; You YK
    World J Gastrointest Surg; 2023 Dec; 15(12):2727-2738. PubMed ID: 38222009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.